News und Analysen

Thanks to the in-depth transformation work carried out, GECI International is reporting a strong improvement in its results and a positive net income figure for the full year

During the Board

GECI International, the Digital Transformation and Technology Consulting specialist, is reporting pro forma¹ full-year revenues of €16.5m, down 26% from the previous year on a comparable basis.

Bei Hitachi Metals, Ltd. (HML) freuen wir uns, unsere wiederbelebte Website für 2021 präsentieren zu dürfen. Das neue Design ist so konzipiert, dass die Kunden genauer navigieren und die

Bei Hitachi Metals, Ltd. (HML) freuen wir uns, unsere wiederbelebte Website für 2021 präsentieren zu dürfen. Das neue Design ist so konzipiert, dass die Kunden genauer navigieren und die

Bei Hitachi Metals, Ltd. (HML) freuen wir uns, unsere wiederbelebte Website für 2021 präsentieren zu dürfen. Das neue Design ist so konzipiert, dass die Kunden genauer navigieren und die

Bei Hitachi Metals, Ltd. (HML) freuen wir uns, unsere wiederbelebte Website für 2021 präsentieren zu dürfen. Das neue Design ist so konzipiert, dass die Kunden genauer navigieren und die

Hitachi Metals, Ltd. (HML) is pleased to announce our revitalized website for 2021. The new format is designed to help customers more precisely navigate and understand the outstanding medical

Hitachi Metals, Ltd. (HML) is pleased to announce our revitalized website for 2021. The new format is designed to help customers more precisely navigate and understand the outstanding medical

Hitachi Metals, Ltd. (HML) is pleased to announce our revitalized website for 2021. The new format is designed to help customers more precisely navigate and understand the outstanding medical

Hitachi Metals, Ltd. (HML) is pleased to announce our revitalized website for 2021. The new format is designed to help customers more precisely navigate and understand the outstanding medical

Transfer of GECI International shares to the Euronext Growth market with effect from March 29, 2021

GECI International, the Digital Transformation and Technology Consulting specialist, is

Hitachi Metals, Ltd. (hereinafter “Hitachi Metals”) is pleased to announce that it has entered into a licensing agreement with Teikuro Inc. (hereinafter “Teikuro”) for the technical provision of

Hitachi Metals, Ltd. (hereinafter “Hitachi Metals”) is pleased to announce that it has entered into a licensing agreement with Teikuro Inc. (hereinafter “Teikuro”) for the technical provision of

Hitachi Metals, Ltd. (hereinafter “Hitachi Metals”) is pleased to announce that it has entered into a licensing agreement with Teikuro Inc. (hereinafter “Teikuro”) for the technical provision of

Hitachi Metals, Ltd. (hereinafter “Hitachi Metals”) is pleased to announce that it has entered into a licensing agreement with Teikuro Inc. (hereinafter “Teikuro”) for the technical provision of

At the Board meeting on December 17, 2020, the Directors reviewed and approved the 2020-21 half-year financial statements for the period ended September 30, 2020.

During the Board meeting on July 30, 2020, the Directors reviewed and approved the annual financial statements for FY 2019-20, ended March 31, 2020.

Consolidated financials

Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an